Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay
about
sameAs
Role of C-reactive protein in cardiovascular diseaseEffect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic strokeC-reactive protein (CRP)-lowering agentsClinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic diseaseCritical appraisal of C-reactive protein throughout the spectrum of cardiovascular diseaseClopidogrel: the data, the experience, and the controversies.Aspirin adherence, aspirin dosage, and C-reactive protein in the first 3 months after acute coronary syndrome.Aspirin and platelet adenosine diphosphate receptor antagonists in acute coronary syndromes and percutaneous coronary intervention: role in therapy and strategies to overcome resistance.Inflammatory bio-markers and cardiovascular risk prediction.Association between Regular Aspirin Use and Circulating Markers of Inflammation: A Study within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialPharmacotherapy for dyslipidaemia--current therapies and future agents.Relation between C reactive protein concentrations and coronary microvascular endothelial functionIncreased high sensitivity C reactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease.Increased titres of anti-human heat shock protein 60 predict an adverse one year prognosis in patients with acute cardiac chest painFactors associated with inflammation markers, a cross-sectional analysis.Effects of weight loss and pharmacotherapy on inflammatory markers of cardiovascular disease.Comparison of the influence of ticagrelor and clopidogrel on inflammatory biomarkers and vascular endothelial function for patients with ST-segment elevation myocardial infarction receiving emergency percutaneous coronary intervention: study protocoAssociation between use of specialty dietary supplements and C-reactive protein concentrations.An assessment of the joint associations of aspirin and statin use with C-reactive protein concentration.New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor.Circulating levels of inflammatory cytokines and risk of colorectal adenomas.Concomitant reduction of low-density lipoprotein-cholesterol and biomarkers of inflammation with low-dose simvastatin therapy in patients with type 1 diabetes.Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications.To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers.Antagonistic effects of aspirin and folic acid on inflammation markers and subsequent risk of recurrent colorectal adenomasTargeting Inflammation Through a Physical Active Lifestyle and Pharmaceuticals for the Treatment of Type 2 Diabetes.Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism.Beneficial effects of low-dose aspirin on aortic stiffness in hypertensive patients.Preconception Low-Dose Aspirin Restores Diminished Pregnancy and Live Birth Rates in Women With Low-Grade Inflammation: A Secondary Analysis of a Randomized Trial.Obesity and Age-Related Changes in Markers of Oxidative Stress and Inflammation Across Four Generations.Inflammation and platelet activation in peripheral arterial occlusive disease.Aspirin Use Reduces the Risk of Aggressive Prostate Cancer and Disease Recurrence in African-American Men.Serum C-reactive protein and plasma homocysteine levels are associated with hormone therapy use and other factors: a population-based study of middle-aged Australian-born women.Effects of mealtime insulin aspart and bedtime NPH insulin on postprandial inflammation and endothelial cell function in patients with type 2 diabetes.C-reactive protein distribution and correlates among men and women with chronic coronary heart disease.Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders?Clopidogrel discontinuation and platelet reactivity following coronary stentingThe course of high-sensitive C-reactive protein in correlation with pain and clinical function in patients with acute lumbosciatic pain and chronic low back pain-A 6 months prospective longitudinal study
P2860
Q28166927-57428F43-01FF-42D6-97D3-D45516D62B00Q28194573-4696A886-0E6B-45C7-8F9C-F7942506D80BQ28200344-5DD3BAF6-FADC-4516-9F25-4F4ABAB78447Q28218124-6C8F2599-2984-4A44-BC26-1FC247F3C9AAQ28219483-088987CE-4960-419B-B7E0-C6BCF1488D8DQ30573045-0D0ACBC4-8084-4245-A962-3ED849770438Q34257748-9EDAF5FE-B550-410A-8A12-111D328F2BD4Q34771381-A663B191-9F87-4714-8C0B-F53AF15D9824Q34941391-6B49FB40-C4ED-42CA-BAEC-A26A440389D9Q35562771-8E0329DD-8E26-4331-A622-F8E8DA6F1CC1Q35574960-013440A2-8A33-4BF1-B2AE-B4E373A73421Q35582574-9449C88A-568F-487A-AB2E-1F321E4839B4Q35583092-FED3DDA7-469D-4997-A29E-7C0B320994C0Q35584657-7D8AFBAF-CDE8-4E77-97CA-A4C8EEA1865AQ35633792-DD86AD15-DF74-494E-8BCA-A7A510102102Q36216863-FEA57E87-AD34-4015-9C38-292D34B3FF81Q36570244-D82AA8EF-E5F1-46A5-9D2F-C4CB3536B544Q36606633-4093DB5B-E370-4D02-ACE7-D7486F5A72C7Q36851683-618A1A05-F007-438E-84CF-60BC666C020DQ36897456-C4CD9B7C-5E67-47BD-A132-45B0E2B82FA5Q37175902-4DA2768B-4BFE-42BA-BBCB-B0E625576A01Q37181767-C060F0FF-7DBB-4275-A4C4-25DE9211B25DQ37218448-AD72DEF1-28C4-490C-9B76-5E8892BF2A90Q37359748-443CC4D9-6482-4E33-B657-26D789965385Q37452734-3739E434-6973-4F7A-BDA8-B6BF91335B9EQ38584502-DCD90FA3-8168-4DF7-945B-6781748A0051Q38741861-B2308623-EBA2-43B0-BB93-317CC65CB1AAQ39104909-32777F61-91DB-4D5A-843A-9C8B9ED8A56BQ40282636-505B20CF-DD23-4F2B-AB52-F53E53EC29FBQ40769551-A7BEB718-B390-4450-A6E1-66B82495F838Q42536670-13FB8CB8-ED6C-435D-B7D1-C531F8C28685Q46176546-C3BE67A5-7A0B-4BFB-8287-97CFC503D16DQ46877655-C866BA17-1FA4-482F-A143-97A721195D4BQ48140197-42918D8A-5A26-498F-8942-468933BC4EB1Q51767737-B3834182-B6CA-401A-B2F4-DF3CE72197E3Q52672848-C5CF4FF9-570B-4C19-9B77-067A33F7867EQ57098373-F2FA7844-24D7-4035-AEC5-EEE54DA1DD78Q57192479-AE02D9A2-4146-4C50-A11D-1F824FD8B3ED
P2860
Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Effects of low-dose aspirin on ...... itive C-reactive protein assay
@ast
Effects of low-dose aspirin on ...... itive C-reactive protein assay
@en
Effects of low-dose aspirin on ...... itive C-reactive protein assay
@nl
type
label
Effects of low-dose aspirin on ...... itive C-reactive protein assay
@ast
Effects of low-dose aspirin on ...... itive C-reactive protein assay
@en
Effects of low-dose aspirin on ...... itive C-reactive protein assay
@nl
prefLabel
Effects of low-dose aspirin on ...... itive C-reactive protein assay
@ast
Effects of low-dose aspirin on ...... itive C-reactive protein assay
@en
Effects of low-dose aspirin on ...... itive C-reactive protein assay
@nl
P2093
P1476
Effects of low-dose aspirin on ...... itive C-reactive protein assay
@en
P2093
P304
P356
10.1016/S0735-1097(01)01289-X
P407
P577
2001-06-15T00:00:00Z